Insulet automated insulin delivery system Omnipod 5 gets CE mark

Sep. 20, 2022 9:52 AM ETInsulet Corporation (PODD)By: Ravikash, SA News Editor1 Comment

Word diabetes laid out from sugar isolated on a blue background

Tatiana/iStock via Getty Images

  • Insulet's (NASDAQ:PODD) Omnipod 5 automated insulin delivery system received CE mark in EU for individuals aged two years and older with type 1 diabetes.
  • Omnipod 5 is the first CE marked tubeless hybrid closed loop system (also known as automated insulin delivery) which integrates with the Dexcom G6 Continuous Glucose Monitoring (CGM) system to automatically adjust insulin, the company said in a Sept. 20 press release.
  • Insulet expects Omnipod 5 to be available in select countries starting mid-2023.

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.